Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre Implications for Cancer Care Policy
Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre Implications for Cancer Care Policy
复制标题
DOI:
10.1097/sla.0000000000004116
复制
发表时间:
2020-09-01
影响因子:
9
通讯作者:
Badwe, Rajendra A.
中科院分区:
文献类型:
--
作者:
Shrikhande, Shailesh V.;Pai, Prathmesh S.;Badwe, Rajendra A.
Background: Overburdened systems and concerns of adverse outcomes have resulted in deferred cancer surgeries with devastating consequences. In this COVID pandemic, the decision to continue elective cancer surgeries, and their subsequent outcomes, are sparsely reported from hotspots. Methods: A prospective database of the Department of Surgical Oncology was analysed from March 23rd to April 30th, 2020. Findings: Four hundred ninety-four elective surgeries were performed (377 untested and 117 tested for Covid 19 before surgery). Median age was 48 years with 13% (n = 64) above the age of 60 years. Sixty-eight percent patients were American Society of Anaesthesiology (ASA) grade I. As per surgical complexity grading, 71 (14 center dot 4%) cases were lower grade (I-III) and 423 (85.6%) were higher grade complex surgeries (IV - VI). Clavien-Dindo >= grade III complications were 5.6% (n = 28) and there were no postoperative deaths. Patients >60 years documented 9.3% major complications compared to 5.2% in